PHIO PHARMACEUTICALS CORP (PHIO) Stock Cash Flow
NASDAQ:PHIO - Nasdaq - US71880W5013 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -6.76M | -7.15M | -10.83M | -11.48M | -13.29M | |||
| Depreciation Amortization | 5.00K | 35.00K | 184.00K | 70.00K | 80.00K | |||
| Income Taxes - Deferred | N/A | N/A | N/A | N/A | N/A | |||
| Change In Working Capital | 243.00K | -138.00K | -536.00K | -1.26M | 990.00K | |||
| Interest Paid | N/A | 13.00K | N/A | N/A | 10.00K | |||
| Other non cash items | 144.00K | 141.00K | 429.00K | 540.00K | 360.00K | |||
| OPERATING CASH FLOW | -6.38M | -7.11M | -10.75M | -12.13M | -11.86M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | -1.00K | -5.00K | -120.00K | -50.00K | |||
| Other Investing Activity | N/A | 9.00K | N/A | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 8.00K | -5.00K | -120.00K | -50.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | N/A | N/A | N/A | 0.00 | |||
| Stock Issued/Repurchased | 13.18M | 4.00M | 7.45M | 0.00 | 21.72M | |||
| Other Financing Activity | -6.00K | -6.00K | -37.00K | -30.00K | 0.00 | |||
| FINANCING CASH FLOW | 13.17M | 4.00M | 7.41M | -30.00K | 21.72M | |||
| CHANGE IN CASH | 6.81M | -3.11M | -3.34M | -12.28M | 9.81M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -6.38M | -7.11M | -10.75M | -12.13M | -11.86M | |||
| Capital Expenditure | N/A | -1.00K | -5.00K | -120.00K | -50.00K | |||
| FREE CASH FLOW | -6.38M | -7.11M | -10.75M | -12.25M | -11.91M | |||
All data in USD